A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy
Burton Needles, Eduardo Miranda, Francisco M. Garcia Rodriguez, Luis Baez Diaz, Jesse Spector, Johnny Craig, Gary Cohen, Steven Krasnow, J. Brogden, Michael Ames, on behalf of the S3AA3012 Study GroupVolume:
7
Language:
english
Pages:
7
DOI:
10.1007/s005200050274
Date:
August, 1999
File:
PDF, 63 KB
english, 1999